TG Therapeutics

TG Therapeutics TGTX

30.58 -3.02%

High: 32.11 Low: 30.35

TG Therapeutics Inc. Company that develops treatments for patients wit B-cell malignancies and autoimmune diseases. Based in New York. Yahoo! Finance

Add to watchlist Set alert

Traders' Sentiments

Info

TG Therapeutics Inc. Company that develops treatments for patients wit B-cell malignancies and autoimmune diseases. Based in New York. Yahoo! Finance

	0.23		0.75%
	-0.05892%		-0.0288%
	20.00%		10.00%
	1:5		No

Related Instruments

Name	Sell	Sell button / Change	Buy		Change
		Sell		Buy		Trade

What is TG Therapeutics?

TG Therapeutics (NASDAQ: TGTX) is an American biopharmaceutical company focused on leveraging leverage scientific advances in B-cell biology to develop novel patient treatments. The FDA approved its BRIUMVI drug for multiple sclerosis. The TGTX share price can depend on clinical trials, regulatory approvals, competition, healthcare policies, and investor sentiment. Partnerships, licensing agreements, and mergers and acquisitions also impact investor confidence and stock performance.

How do I trade TG Therapeutics?

Start trading TG Therapeutics in just 5 steps:

Explore what shifts the TG Therapeutics price
Learn about TG Therapeutics trading in the Trading Academy
Open and verify your Plus500 account
Develop your trading strategy
Execute your first trade on TG Therapeutics

Learn More About TG Therapeutics

TG Therapeutics Stock Guide: TGTX Share Price Explained

Explore Shares

Related News & Market Insights

Trump Boosts Tesla, CPI Sends Nasdaq Soaring

Trump Boosts Tesla, CPI Sends Nasdaq Soaring

On Wednesday, 11 December, Trump’s re-election boosted Tesla’s stock as the Nasdaq and tech stocks soared, driven by rate cut hopes. Explore more in this article.

Alphabet Stock Jumps on Quantum Chip Breakthrough

Alphabet Stock Jumps on Quantum Chip Breakthrough

Alphabet (GOOG) stock jumped 5.3% on 10 December after Google unveiled Willow, a quantum chip that marks a milestone in quantum computing by solving a problem classical systems couldn't tackle.

Nasdaq Hits Record, Salesforce Beats Earnings Estimates

Nasdaq Hits Record, Salesforce Beats Earnings Estimates

The Nasdaq soared to a record high on Tuesday, 3 December, driven by strong gains in Palantir and Meta. Salesforce jumped 10% after hours on upbeat earnings, while Palantir rose 6% on US government cloud contracts. The tech rally signals growing investor confidence as the year-end approaches.

More News

Why Plus500?

Protected & secure

Your data is safe and your funds are kept in segregated bank accounts, in accordance with regulatory requirements.

Professional support

Get around-the-clock dedicated customer service in multiple languages.

Regulated

Plus500CY Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission (Licence No. 250/14).

Reliable

Plus500 Ltd is a FTSE 250 company listed on the London Stock Exchange’s Main Market for Listed Companies.

Start Trading Now Try Free Demo

Need Help?